ArticleCureus2026
Neuropsychiatric Systemic Lupus Erythematosus Presenting With Striatal Lupus Encephalitis and Catatonia: A Multidisciplinary Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuropsychiatric lupus represents one of the most complex and heterogeneous manifestations of systemic lupus erythematosus (SLE). Presentations may include cognitive dysfunction, mood disorders, psychosis, seizures, and movement disorders, often mimicking primary neurological or psychiatric conditions. We report the case of a woman with established SLE who developed acute behavioural change, cognitive decline, and psychomotor agitation progressing to catatonia. Neuroimaging demonstrated symmetrical basal ganglia abnormalities with associated cortical and basal ganglia microinfarcts. Extensive investigation excluded infectious, embolic, and primary neurodegenerative causes. The clinical picture was ultimately attributed to striatal lupus encephalitis, a rare manifestation of neuropsychiatric SLE (NPSLE). She was treated with high-dose corticosteroids and intravenous cyclophosphamide with subsequent clinical improvement, while catatonic symptoms responded rapidly to benzodiazepine therapy. Repeat MRI showed partial regression of basal ganglia abnormalities but new microinfarcts. This case highlights the evolving nature of NPSLE, the importance of multidisciplinary collaboration, and the need to consider autoimmune mechanisms in atypical neuropsychiatric presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.